How to manage infections after hematopoietic stem cell transplantation and the issue of resistance
Translational research in Berlin to improve AML treatment outcomes
Encouraging data from the RAY trial 3-year follow-up
Venetoclax combination therapy for relapsed CLL
FCR or FR – which regimen is better for treating CLL?